BAALC-AS1

Across TCGA pan-cancer cohorts, BAALC-AS1 RNA differs between tumor and matched normal tissue in 9 of 18 cancer types tested, making tumor–normal expression one of BAALC-AS1’s most consistent transcriptional readouts.

The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where BAALC-AS1 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types BAALC-AS1 is over-expressed in tumor, although a few such as KIRC and LUAD show the opposite, repressed pattern.

HNSC, KIRC, and LIHC are the cancer types where BAALC-AS1 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in BAALC-AS1 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
HNSC	All	III,IV	+0.994	<.001	11	view →
KIRC	All	II,III,IV	−0.459	<.001	10	view →
LIHC	Male	All	+0.378	<.001	8	view →
LUAD	Female	III,IV	−0.623	<.001	6	view →
CHOL	All	All	+1.105	<.001	5	view →
THCA	Male	All	−0.319	.004	5	view →
KICH	All	All	−0.501	.006	2	view →
KIRP	All	All	−0.369	.001	2	view →
STAD	Male	All	+0.510	.029	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 9 strongest of 9 lineages.

BAALC-AS1–HNSC

Open the HNSC breakdown →